Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 18Colorectal Neoplasms 16Rectal Neoplasms 11Colonic Neoplasms 8Stomach Neoplasms 6Urinary Bladder Neoplasms 5Ovarian Neoplasms 4Neoplasm Metastasis 4Anus Neoplasms 4Adenocarcinoma Of Esophagus 4Squamous Cell Carcinoma of Head and Neck 3Pancreatic Adenocarcinoma 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Esophageal Neoplasms 3Clinical Stage I Gastric Cancer AJCC v8 3Cholangiocarcinoma 3Oropharyngeal Neoplasms 2Lung Neoplasms 2Klatskin Tumor 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Borderline Resectable Pancreatic Adenocarcinoma 2Bile Duct Neoplasms 2Appendiceal Neoplasms 2Anal Canal Carcinoma 2Uterine Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1

Interventions

Radiotherapy 2Docetaxel 2Cisplatin 2Carboplatin 2toripalimab 1enasidenib 1dehydroftorafur 1Radiotherapy, Intensity-Modulated 1Radiation 1Protons 1Platinum 1Fluorouracil 1Chemoradiotherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sinonasal undifferentiated carcinoma × dehydroftorafur × Clear all
NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡